Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
DPT Manager Elected to DCAT Board

December 1, 2010
Pam Tyler, a purchasing manager at DPT Laboratories, was recently recognized by the Drug, Chemical and Associated Technology Association (DCAT) for her service to the organization.   Read More »
PharmaNet

November 30, 2010
Chris Beaver, Ph.D. has been appointed director of Immunochemistry Services at PharmaNet Development Group.  Read More »
Merck

November 30, 2010
Kenneth C. Frazier, currently president of Merck, has been appointed chief executive officer and president of the company, as well as a member of the board, effective January 1, 2011.  Read More »
RiconPharma Acquires NJ Manufacturing Facility

November 30, 2010
RiconPharma has acquired a cGMP pharmaceutical manufacturing company in Fairfield, NJ to be called Mirror Pharmaceuticals LLC.   Read More »
Array Achieves Celgene Milestone

November 30, 2010
Array BioPharma has achieved a $10 million clinical research milestone in its collaboration with Celgene, with the planned initiation of a Phase I dose escalation trial in cancer patients with ARRY-382, a small molecule cFMS inhibitor.  Read More »
Almac Adds Late Stage Customization Suite

November 29, 2010
Almac has added a dedicated late stage customization suite to its commercial facilities in Europe.  Read More »
Pfizer, Protalix Submit MAA for Gaucher Disease Drug

November 29, 2010
Pfizer and Protalix BioTherapeutics have submitted a Marketing Authorization Application to the EMA for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD), for the treatment of Gaucher disease.  Read More »
Accentia, Baxter Enter Cytoxan Alliance

November 29, 2010
Accentia Biopharmaceuticals has entered a strategic agreement with Baxter Healthcare providing Accentia the exclusive, worldwide right to purchase Baxter’s cyclophosphamide — marketed under the brand name Cytoxan — for the treatment of a  Read More »
Quintiles, London Genetics Offer Pharmacogenetics Solutions

November 29, 2010
Quintiles and London Genetics have entered a strategic alliance to offer pharmacogenetics solutions to the biopharmaceutical industry in an effort to advance personalized medicine.  Read More »
GSK Sells U.S. Penicillin Facility to Dr. Reddy’s

November 24, 2010
GlaxoSmithKline will transfer ownership of its penicillin manufacturing site in Bristol, TN, and rights for the Augmentin and Amoxil brands in the U.S. to Dr. Reddy’s Laboratories.  Read More »
Lilly, Acrux Gain Approval for Testosterone Therapy

November 24, 2010
Eli Lilly and Co. and Acrux received approval from the FDA for Axiron (testosterone) topical solution CIII for replacement therapy in men for conditions associated with a deficiency or absence of testosterone.  Read More »
Hospira

November 23, 2010
Francois (Frans) L. Dubois has been named to the newly created position of senior vice president of Quality at Hospira, Inc., effective Jan. 3, 2011.  Read More »
Abbott’s Phase II Kidney Drug Shows Promise

November 23, 2010
Abbott achieved positive results from a Phase II dose-ranging study of atrasentan, a highly selective endothelin A receptor antagonist in development to help slow chronic kidney disease (CKD) progression in patients with type 2 diabetic kidney disease.  Read More »
Evotec, Merck KGaA Enter CNS Development Pact

November 23, 2010
Evotec AG, through the NEU(2) consortium, has signed an agreement with Merck KGaA to develop pre-clinical candidates for an undisclosed neurological disease.   Read More »
Bayer, Regeneron Wet AMD Drug Shows Promise

November 22, 2010
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare achieved positive results from two parallel Phase III studies in patients with the neovascular form of age-related macular degeneration (wet AMD), with all regimens of VEGF Trap-Eye (aflibercept ophthal  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: